TipRanks
Clearmind Medicine (CMND)
NASDAQ:CMND
US Market
Want to see CMND full AI Analyst Report?

Clearmind Medicine (CMND) Financial Statements

― Followers

Clearmind Medicine Financial Overview

Clearmind Medicine's market cap is currently $3.01M. The company's EPS TTM is -89.2; its P/E ratio is -0.07; Clearmind Medicine is scheduled to report earnings on September 10, 2026, and the estimated EPS forecast is ―. See an overview of income statement, balance sheet, and cash flow financials.
Oct 25Oct 24Oct 23Jan 23Jan 22
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00C$ 0.00C$ 0.00
Gross Profit$ -49.36K$ -51.07K$ -57.43KC$ -119.62KC$ -2.53K
Operating Income$ -5.67M$ -5.74M$ -6.29MC$ -9.00MC$ -3.61M
EBITDA$ -3.72M$ -4.79M$ -8.53MC$ -9.75M-
Net Income$ -3.86M$ -5.25M$ -8.61MC$ -9.93MC$ -3.66M
Balance Sheet
Cash & Short-Term Investments$ 5.58M$ 9.55M$ 5.51MC$ 437.77KC$ 3.71M
Total Assets$ 6.08M$ 10.10M$ 5.95MC$ 1.12MC$ 4.16M
Total Debt$ 1.78M$ 73.97K$ 0.00C$ 52.11KC$ 0.00
Net Debt$ -2.14M$ -9.08M$ -5.43MC$ -122.68KC$ -3.71M
Total Liabilities$ 4.89M$ 5.77M$ 4.97MC$ 2.62MC$ 288.19K
Stockholders' Equity$ 1.19M$ 4.33M$ 983.47KC$ -1.50MC$ 3.87M
Cash Flow
Free Cash Flow$ -4.73M$ -6.76M$ -6.30MC$ -5.06MC$ -2.25M
Operating Cash Flow$ -4.73M$ -6.76M$ -6.30MC$ -5.06MC$ -2.08M
Investing Cash Flow$ -541.97K$ -331.43K$ -26.23KC$ -7.55KC$ -184.03K
Financing Cash Flow$ 2.62M$ 8.71M$ 11.66MC$ 694.52KC$ 5.39M

Clearmind Medicine Earnings and Revenue History

Clearmind Medicine Debt to Assets

Clearmind Medicine Cash Flow

Clearmind Medicine Forecast EPS vs Actual EPS